Details for New Drug Application (NDA): 020486
✉ Email this page to a colleague
The generic ingredient in VANCERIL DOUBLE STRENGTH is beclomethasone dipropionate. There are twenty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the beclomethasone dipropionate profile page.
Summary for 020486
Tradename: | VANCERIL DOUBLE STRENGTH |
Applicant: | Schering |
Ingredient: | beclomethasone dipropionate |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | AEROSOL, METERED;INHALATION | Strength | 0.084MG/INH | ||||
Approval Date: | Dec 24, 1996 | TE: | RLD: | No |
Expired US Patents for NDA 020486
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Schering | VANCERIL DOUBLE STRENGTH | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 020486-001 | Dec 24, 1996 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription